Exposure therapy has evolved quite a bit in the past 70 years, with substantial advances in research and practice within the past decade. This presentation will focus on the most recent shift in exposure therapy–a clinician’s ability to maximize exposure-based learning through a model of inhibitory learning. Intermediate to advanced practitioners with some basic knowledge of exposure therapy will benefit most from this presentation. This presentation will also address the impact of the COVID-19 pandemic on effective application of exposure interventions. An update will also be provided of empirical support behind applying exposure therapy to a range of mental health diagnoses.
After leaving this second presentation by this speaker, participants will be able to:
1) Report on the latest findings around anxiety disorders and depression – from screening & assessment to pharmacologic and non-pharma treatments; and,
2) Design treatment plans for individuals with various anxiety and/or depressive disorders which implement the modalities currently believed to be most effective.
